Hung Chang

9PUBLICATIONS

12CO-AUTHORS

Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityPredictive and prognostic markersHaematology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 19, 2026

β2-microglobulin is superior to lactate dehydrogenase and bulky disease for risk stratification in diffuse large B-cell lymphoma patients with IPI 1-2.

|Aug 04, 2025

Addition of romiplostim to immunosuppressive therapy as first-line treatment for patients with aplastic anemia.

Jong Wook Lee, Jun Ho Jang, Hirohito Yamazaki

|Jun 30, 2025

Risk factors and clinical consequences of rituximab infusion-related reactions.

Chi-Hsiang Hou, Hung Chang, Yuen-Chin Ong

|Mar 20, 2025

Prognostic impact of pre-treatment and post-treatment plasma Epstein-Barr virus DNA in peripheral T-cell lymphomas.

Chu-Yi Chan, Tung-Liang Lin, Ming-Chung Kuo

|Feb 09, 2022

Changing profile of platelet activity and turnover indices during treatment response of immune thrombocytopenia.

Chewei Ou, Hung Chang, Yu-Shin Hung

|Aug 27, 2021

Evolution of <sup>18</sup>F-FDG Uptake as a Pitfall of Image Diagnosis for Systemic Anaplastic Large Cell Lymphoma.

Hung Chang, Wen-Yu Chuang

Pageof 2

Frequent Collaborators

Lee-Yung Shih

Wen-Yu Chuang

Chu-Yi Chan

Tung-Liang Lin

Yi-Jiun Su

Hsiao-Wen Kao

Jong Wook Lee

Hirohito Yamazaki

Yoshiaki Tomiyama

Koji Nagafuji

Frequent Collaborators

Lee-Yung Shih

Wen-Yu Chuang

Chu-Yi Chan

Tung-Liang Lin